Integrated REMS and Patient Support Services Solution for Complex Rare Disease

Download our integrated Risk Evaluation and Mitigation Strategy (REMS) and Patient Support Program case study for unique experience with chronic treatment management and regulatory requirements of a complex rare disease.

Discover how UBC has been the single point of contact for over 10 years to reduce program risk and burden through multiservice governance for 28,000 patients.

Our leading team of REMS experts helped our pharmaceutical sponsor easily maneuver through complicated rare disease challenges, including:     

  • FDA requirement for a REMS
  • Specialized approach to stakeholder involvement
  • High cost and complex payer coverage

Learn how our highly functional REMS solution has simplified enrollment processes, monitored for compliance, and provided quick and ongoing stakeholder support.

Simply complete the form to the right to read the full REMS and Patient Support Program case study.

UBC is the leading provider of risk management and REMS services. Our REMS consultation, design, and implementation aim to reduce stakeholder burden, minimize barriers to access, and ensure product safety and value.

UBC Pinwheel logo
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.